Llovet et al. reported on Ang-2 plasma levels as a strong, independent prognosis predictor in patients with HCC, since high Ang-2 plasma levels correlated with poor survival, shorter time to progression and several other clinical/demographic variables associated with a poor outcome in advanced HCC [60]. The gene discussed is ANGPT2; the disease is hepatocellular carcinoma.